Seifert SA - Search Results

1

The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(ab')₂ Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.

Dart RC, Bush SP, Heard K, Arnold TC, Sutter M, Campagne D, Holstege CP, Seifert SA, Lo JCY, Quan D, Borron S, Meurer DA, Burnham RI, McNally J, Garcia-Ubbelohde W, Anderson VE. Dart RC, et al. Among authors: seifert sa. Ann Emerg Med. 2019 Sep;74(3):439-449. doi: 10.1016/j.annemergmed.2019.02.007. Epub 2019 Mar 27. Ann Emerg Med. 2019. PMID: 30926190 Clinical Trial.

2

Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning.

Dart RC, Seifert SA, Carroll L, Clark RF, Hall E, Boyer-Hassen LV, Curry SC, Kitchens CS, Garcia RA. Dart RC, et al. Among authors: seifert sa. Ann Emerg Med. 1997 Jul;30(1):33-9. doi: 10.1016/s0196-0644(97)70107-0. Ann Emerg Med. 1997. PMID: 9209222 Clinical Trial.

3

Relationship of venom effects to venom antigen and antivenom serum concentrations in a patient with Crotalus atrox envenomation treated with a Fab antivenom.

Seifert SA, Boyer LV, Dart RC, Porter RS, Sjostrom L. Seifert SA, et al. Ann Emerg Med. 1997 Jul;30(1):49-53. doi: 10.1016/s0196-0644(97)70110-0. Ann Emerg Med. 1997. PMID: 9209225

4

Accidental, intravenous infusion of a peanut oil-based medication.

Seifert SA, Dart RC, Kaplan EH. Seifert SA, et al. J Toxicol Clin Toxicol. 1998;36(7):733-6. doi: 10.3109/15563659809162624. J Toxicol Clin Toxicol. 1998. PMID: 9865244

5

Recurrent and persistent coagulopathy following pit viper envenomation.

Boyer LV, Seifert SA, Clark RF, McNally JT, Williams SR, Nordt SP, Walter FG, Dart RC. Boyer LV, et al. Among authors: seifert sa. Arch Intern Med. 1999 Apr 12;159(7):706-10. doi: 10.1001/archinte.159.7.706. Arch Intern Med. 1999. PMID: 10218750

6

Olanzapine overdose mimicking opioid intoxication.

O'Malley GF, Seifert S, Heard K, Daly F, Dart RC. O'Malley GF, et al. Ann Emerg Med. 1999 Aug;34(2):279-81. doi: 10.1016/s0196-0644(99)70249-0. Ann Emerg Med. 1999. PMID: 10424936

7

Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies.

Seifert SA, Boyer LV. Seifert SA, et al. Ann Emerg Med. 2001 Feb;37(2):189-95. doi: 10.1067/mem.2001.113135. Ann Emerg Med. 2001. PMID: 11174238 Review.

8

Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline Fab antivenom.

Boyer LV, Seifert SA, Cain JS. Boyer LV, et al. Among authors: seifert sa. Ann Emerg Med. 2001 Feb;37(2):196-201. doi: 10.1067/mem.2001.113134. Ann Emerg Med. 2001. PMID: 11174239 Review.

9

A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States.

Dart RC, Seifert SA, Boyer LV, Clark RF, Hall E, McKinney P, McNally J, Kitchens CS, Curry SC, Bogdan GM, Ward SB, Porter RS. Dart RC, et al. Among authors: seifert sa. Arch Intern Med. 2001 Sep 10;161(16):2030-6. doi: 10.1001/archinte.161.16.2030. Arch Intern Med. 2001. PMID: 11525706 Clinical Trial.

10

ACMT Position Statement: Institutions housing venomous animals.

Seifert SA, Keyler D, Isbister G, McNally J, Martin TG. Seifert SA, et al. J Med Toxicol. 2006 Sep;2(3):118-9. doi: 10.1007/BF03161024. J Med Toxicol. 2006. PMID: 18077885 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters